Creative Biolabs-Immuno-oncology

Anti-EGP2 (clone MOC31G) SynExpress SV-BF-I4-K Modified CD8+ T cells (CAT#: ITS-1224-CR2629)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target EGP2 (clone MOC31G). We employs the pUC (SV40-BFP-IL-4-KpnI) vector components and the SynExpress system of the Introns Knockout/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
EGP2
Clone
MOC31G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
BFP
Promoter
SV40
Effector Gene
IL-4
Insertion Sites
KpnI
Gene Modification
Knockout
Modification Domain
Introns
Carrier Type
pUC
Transformation Accuracy
0.87
Cell Culture
Adherent Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving